Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Calcif Tissue Int ; 74(6): 509-15, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15354858

RESUMO

We investigated the relationships between tumor necrosis factor (TNF) gene polymorphism, circulating TNF-alpha (TNF-alpha) concentrations, and bone mineral density (BMD) in the lumbar spine. TNF gene polymorphisms studied were the Nco I polymorphism within the first intron of TNF-beta (TNF-beta) and three single nucleotide polymorphisms in the promoter region of the TNF-alpha gene, at positions -857, -863, and -1031. Allelic variants of the TNF gene were identified using restriction fragment length polymorphism (RFLP) analysis in 177 postmenopausal Japanese women within 10 years after menopause, aged 56.4 +/- 4.5 years (mean +/- SD). A significantly higher prevalence of the alleles TNF-alpha-863A (20.3% versus 9.9%) and TNF-alpha-1031C (21.3% versus 12.4%) was seen in the low BMD group (Z-score < 0, n = 91) than in the high BMD group (0 < Z-score, n = 86). In genotype analysis, although difference did not reach a significant level, women with the rarest allelic variants, i.e., homozygous TNFbl, TNF-alpha-863A, and TNF-alpha-1031C, showed the lowest BMD Z-scores. Women with another rarest allelic variant, TNF-alpha-857T/T had significantly lower BMD Z-scores than did women with TNF-alpha-857C/T or -857C/C. The BMD Z-score decreased significantly with an increase in the total number of such rare alleles. Serum concentrations of TNF-alpha did not differ significantly among groups divided by genotypes. Multiple linear regression analysis revealed that the total number of rare alleles, in addition to the body mass index and the number of years since menopause, was an independent predictor of the BMD. These presumptive functional polymorphisms of the TNF gene may be associated with the lumbar spine BMD in early postmenopausal Japanese women.


Assuntos
Povo Asiático , Densidade Óssea/genética , Vértebras Lombares/metabolismo , Polimorfismo de Nucleotídeo Único , Pós-Menopausa , Fator de Necrose Tumoral alfa/genética , Absorciometria de Fóton , Primers do DNA/química , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Japão/epidemiologia , Desequilíbrio de Ligação , Linfotoxina-alfa/genética , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/epidemiologia , Osteoporose Pós-Menopausa/genética , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Fator de Necrose Tumoral alfa/metabolismo
2.
Biochem Biophys Res Commun ; 281(3): 663-9, 2001 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-11237709

RESUMO

The protooncogene Pim-1 encodes serine/threonine protein kinases that are involved in cytokine-mediated cell proliferation and in lymphoma- and leukemogenesis. It is largely unknown how Pim-1 executes its biological effects. Here we show that Pim-1 physically interacts with heat shock protein 90 alpha and beta (Hsp90alpha and beta). The Hsp90-specific inhibitor geldanamycin (GA) induced a rapid degradation of Pim-1 and reduced its kinase activity. The expression of Hsp90alpha was regulated by a signal from the cytokine receptor gp130, as is Pim-1's expression. These results indicate that Hsp90 is coordinately regulated with Pim-1 and is involved in the stabilization and function of Pim-1.


Assuntos
Regulação da Expressão Gênica/fisiologia , Proteínas de Choque Térmico HSP90/fisiologia , Proteínas Serina-Treonina Quinases , Proteínas Proto-Oncogênicas/genética , Sequência de Aminoácidos , Antígenos CD/metabolismo , Sequência de Bases , Linhagem Celular , Receptor gp130 de Citocina , Primers do DNA , Proteínas de Ligação a DNA/metabolismo , Glicoproteínas de Membrana/metabolismo , Dados de Sequência Molecular , Proteínas Proto-Oncogênicas c-pim-1 , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição STAT3 , Transdução de Sinais , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Transativadores/metabolismo
3.
Growth Factors ; 17(2): 81-91, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10595309

RESUMO

Cytokines play roles in a wide range of responses such as immune response, hematopoiesis and inflammation. A large volume of studies revealed that cytokines show functional pleiotropy and redundancy. Gp130 is a receptor subunit shared by the interleukin-6 family of cytokines. We describe and discuss signaling through gp130 in relation to a general scenario for cytokine signaling regulating cell growth, differentiation and survival.


Assuntos
Antígenos CD/fisiologia , Glicoproteínas de Membrana/fisiologia , Transdução de Sinais/fisiologia , Animais , Receptor gp130 de Citocina , Humanos , Modelos Biológicos
4.
Blood ; 93(6): 1809-16, 1999 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-10068651

RESUMO

We previously found that the adapter protein Gab1 (110 kD) is tyrosine-phosphorylated and forms a complex with SHP-2 and PI-3 kinase upon stimulation through either the interleukin-3 receptor (IL-3R) or gp130, the common receptor subunit of IL-6-family cytokines. In this report, we identified another adapter molecule (100 kD) interacting with SHP-2 and PI-3 kinase in response to various stimuli. The molecule displays striking homology to Gab1 at the amino acid level; thus, we named it Gab2. It contains a PH domain, proline-rich sequences, and tyrosine residues that bind to SH2 domains when they are phosphorylated. Gab1 is phosphorylated on tyrosine upon stimulation through the thrombopoietin receptor (TPOR), stem cell factor receptor (SCFR), and T-cell and B-cell antigen receptors (TCR and BCR, respectively), in addition to IL-3R and gp130. Tyrosine phosphorylation of Gab2 was induced by stimulation through gp130, IL-2R, IL-3R, TPOR, SCFR, and TCR. Gab1 and Gab2 were shown to be substrates for SHP-2 in vitro. Overexpression of Gab2 enhanced the gp130 or Src-related kinases-mediated ERK2 activation as that of Gab1 did. These data indicate that Gab-family molecules act as adapters for transmitting various signals.


Assuntos
Proteínas de Neoplasias , Fosfoproteínas/metabolismo , Receptores de Citocinas , Proteínas Adaptadoras de Transdução de Sinal , Sequência de Aminoácidos , Animais , Antígenos CD/fisiologia , Linhagem Celular , Receptor gp130 de Citocina , Expressão Gênica , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Glicoproteínas de Membrana/fisiologia , Camundongos , Dados de Sequência Molecular , Fosfatidilinositol 3-Quinases/metabolismo , Fosfoproteínas/química , Fosfoproteínas/genética , Fosforilação , Proteína Tirosina Fosfatase não Receptora Tipo 11 , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Proteínas Tirosina Fosfatases/metabolismo , Proteínas Proto-Oncogênicas/fisiologia , Proteínas Proto-Oncogênicas c-kit/fisiologia , Receptores de Antígenos de Linfócitos B/fisiologia , Receptores de Antígenos de Linfócitos T/fisiologia , Receptores de Interleucina-3/fisiologia , Receptores de Trombopoetina , Transdução de Sinais , Tirosina/metabolismo
5.
Immunity ; 11(6): 709-19, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10626893

RESUMO

The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. We found that Pim-1 and Pim-2 are targets for the gp130-mediated STAT3 signal. Expression of a kinase-defective Pim-1 mutant attenuated gp130-mediated cell proliferation. Constitutive expression of Pim-1 together with c-myc, another STAT3 target, fully compensated for loss of the STAT3-mediated cell cycle progression, antiapoptosis, and bcl-2 expression. We also identified valosine-containing protein (VCP) as a target gene for the Pim-1-mediated signal. Expression of a mutant VCP led cells to undergo apoptosis. These results indicate that Pim-family proteins play crucial roles in gp130-mediated cell proliferation and explain the synergy between Pim and c-Myc proteins in cell proliferation and lymphomagenesis.


Assuntos
Apoptose , Ciclo Celular/fisiologia , Proteínas de Ligação a DNA/metabolismo , Proteínas Serina-Treonina Quinases , Proteínas Proto-Oncogênicas c-myc/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Transdução de Sinais , Transativadores/metabolismo , Adenosina Trifosfatases , Animais , Antígenos CD/genética , Antígenos CD/metabolismo , Linfócitos B/citologia , Proteínas de Ciclo Celular/metabolismo , Linhagem Celular , Receptor gp130 de Citocina , Humanos , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Camundongos , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-myc/genética , Proteínas Proto-Oncogênicas c-pim-1 , Fator de Transcrição STAT3 , Células Tumorais Cultivadas , Proteína com Valosina
6.
EMBO J ; 17(22): 6670-7, 1998 Nov 16.
Artigo em Inglês | MEDLINE | ID: mdl-9822610

RESUMO

The signal transducer and activator of transcription molecules (STATs) play key roles in cytokine-induced signal transduction. However, their role in cell growth has not been clear. In the present study, we show that STAT3 plays a key role in the G1 to S phase cell-cycle transition induced by the cytokine receptor subunit gp130, through the upregulation of cyclins D2, D3 and A, and cdc25A, and the concomitant downregulation of p21 and p27. Furthermore, unexpectedly, we found that gp130 could induce the expression of p21 when STAT3 activation was suppressed. Such contradictory signals regulating cell-cycle progression could be simultaneously delivered from distinct cytoplasmic regions of gp130. We propose an 'orchestrating model' for cytokine and growth factor action in which contradictory signals are orchestrated to produce a specific effect in a target cell.


Assuntos
Citocinas/farmacologia , Proteínas de Ligação a DNA/metabolismo , Fase G1/efeitos dos fármacos , Fase S/efeitos dos fármacos , Transdução de Sinais , Transativadores/metabolismo , Linhagem Celular , Quinases Ciclina-Dependentes/antagonistas & inibidores , Quinases Ciclina-Dependentes/metabolismo , Regulação para Baixo , Ativação Enzimática , Inibidores Enzimáticos/farmacologia , Fator de Transcrição STAT3
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...